
Suresh Kumar Singh
About Suresh Kumar Singh
Data last updated:
Suresh Kumar Singh is a Whole-Time Director at Shivalik Rasayan Limited (since 1997) and Director at Medicamen Biotech Limited (since 2015). The companies operate in Agriculture and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹489 Cr; the largest is Shivalik Rasayan Limited at ₹320 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 15 Dec 1997 | 1979 | ₹320 Cr (FY 2025) | Active | |
| Director | 31 Dec 2015 | 1993 | ₹169 Cr (FY 2025) | Active |
Board colleagues of Suresh Kumar Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Kumar Singh
Suresh Kumar Singh currently holds 2 directorships: Shivalik Rasayan Limited (Whole-Time Director, since 15 Dec 1997, revenue ₹320 Cr (FY 2025)); Medicamen Biotech Limited (Director, since 31 Dec 2015, revenue ₹169 Cr (FY 2025)).
Suresh Kumar Singh was first appointed on 15 Dec 1997 as Whole-Time Director at Shivalik Rasayan Limited. The most recent appointment on record is 31 Dec 2015 at Medicamen Biotech Limited.
The 2 current companies of Suresh Kumar Singh that report revenue have a combined latest revenue of ₹489 Cr: Shivalik Rasayan Limited ₹320 Cr (FY 2025); Medicamen Biotech Limited ₹169 Cr (FY 2025).
The current boards of Suresh Kumar Singh's companies include Ashwani Kumar Sharma (Shivalik Rasayan Limited), Parul Choudhary (Shivalik Rasayan Limited), Rahul Bishnoi (Shivalik Rasayan Limited), Ramit Madan (Shivalik Rasayan Limited), Ravi Kumar Bansal (Shivalik Rasayan Limited), Sangeeta Bishnoi (Shivalik Rasayan Limited), among others.